First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - SYNERGEN PHARMA DEVELOPMENT LIMITED

ANALYSIS
Credit Risk Update: SYNERGEN PHARMA DEVELOPMENT LIMITED, 1 George Square, Castle Brae, Dunfermline, Fife, KY11 8QF. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 October 2023. The company was incorporated on 29 October 2003.

The accounts next due date is 31 July 2025. There are no mortgages.

The above was based on public record information as at 9 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: SC258396
Date Incorporated: 29 October 2003
Date Latest Accounts: 31 October 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: SYNERGEN PHARMA DEVELOPMENT LIMITED
Registered Number: SC258396
Annual Return: 29 October 2015
Registered Office: 1 George Square, Castle Brae, Dunfermline, Fife, KY11 8QF
SIC Code and Operations: 98200
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

SYNERGEN PHARMA DEVELOPMENT LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 19 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
14759416 SYNERGEN PHARMA LIMITED Active
14103255 SYNERGEN POWER LIMITED Active
08049663 SYNERGEN SCIENTIFIC LIMITED Active
12717978 SYNERGEN UTILITIES LIMITED Active
11945521 SYNERGEN VENTURES LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd